We are live on ! Find out more
HFCIV

H&F Corporate Investors VII Portfolio holdings

AUM $3.61B
1-Year Est. Return 26.49%
This Fund
S&P 500
This Quarter Est. Return
-7.49%
1 Year Est. Return
+26.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.64B
AUM Growth
-$214M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPD
1
DELISTED
PPD, Inc. Common Stock
PPD
$2.64B 100%
77,118,535
– –

Similar funds

DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return
AIC
Ameritas Investment Company Lincoln, Nebraska $2.17B AUM 26.5% 1-Year Est. Return
XEA
XN Exponent Advisors New York $2.09B AUM 32.83% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM

H&F Corporate Investors VII's Q4 2020 Portfolio in Review

As of Q4 2020, H&F Corporate Investors VII held 1 position worth $2.64B, down 7.5% from $2.85B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 0%. H&F Corporate Investors VII opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • H&F Corporate Investors VII's ten largest holdings make up 100% of its $2.64B portfolio in Q4 2020.
  • H&F Corporate Investors VII opened 0 new positions and closed 0 in Q4 2020.
  • H&F Corporate Investors VII's portfolio value fell 7.5% quarter-over-quarter to $2.64B.

Based on H&F Corporate Investors VII's 13F filing for Q4 2020, filed 16 Feb 2021.